Newsroom
Sorted by: Latest
-
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the fourth quarter and full year ended December 31, 2025. “We delivered an exceptional finish to 2025, with strong double-digit growth across both Decipher and Afirma and more than 45,000 patients served with our core testing business in the quarter,” said Marc Stapley, Veracyte’s chief executive officer. “We are achieving this growth while mai...
-
Montrose Environmental Group Reports Record Revenue, Earnings and Cash Flow in 2025; Increases 2026 Guidance
LITTLE ROCK, Ark.--(BUSINESS WIRE)--Montrose Environmental Group, Inc. (the “Company,” “Montrose” or “MEG”) (NYSE: MEG) is on a mission to help protect the air we breathe, the water we drink, and the soil that sustains us to enhance environmental stewardship while supporting economic development. Today, the Company announced results for the fourth quarter and full year periods ended December 31, 2025. Montrose Chief Executive Officer and Director, Vijay Manthripragada, commented, “Over a year a...
-
TrueBlue to Participate in Truist Securities’ Inaugural Human Capital Virtual Conference
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, today announced that it will participate in Truist Securities’ inaugural Human Capital Virtual Conference on Thursday, March 12, 2026. Taryn Owen, President and Chief Executive Officer, and Carl Schweihs, Chief Financial Officer, will host virtual investor meetings throughout the day. For additional information or to request a meeting, please contact your Truist sales representative. Abo...
-
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The J.P. Morgan Global Leveraged Finance Conference, being held in Miami, on Tuesday, March 3, 2026, including a fireside chat at 11:00 a.m. ET. The Leer...
-
TaskUs, Inc. Announces CFO Transition
NEW BRAUNFELS, Texas--(BUSINESS WIRE)--TaskUs, Inc. (Nasdaq: TASK) (“TaskUs” or the “Company”), a leading provider of outsourced digital services and next-generation customer experience to the world’s most innovative companies, today announced that Chief Financial Officer Balaji Sekar has informed the Company of his intention to step down to pursue a role at a private company. He will remain with TaskUs through March 31, 2026, and serve as an advisor for an additional six months to support a sm...
-
IonQ Announces Fourth Quarter and Full Year 2025 Financial Results
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading quantum platform company, today announced financial results for the quarter and full year ending December 31, 2025. “I am pleased to share that IonQ has once again significantly outperformed our revenue guidance range, exceeding the midpoint by 55% for the fourth quarter and 20% for the full year by delivering $61.9 million and $130.0 million respectively,” said Niccolo de Masi, Chairman and CEO. “Our strategic evolution...
-
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2025. “Following a tumultuous 2025, we entered 2026 from a position of strength, founded on: (a) solid financial footing with a robust and growing cash balance, substantial revenue, and no near-term debt overhang, (b) durable approved therapies that are bringing a better life to patients, wi...
-
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2025. “Acadia closed 2025 with another strong quarter, capping a milestone year in which we surpassed $1 billion in annual revenue for the first time,” said Catherine Owen Adams, Chief Executive Officer. “NUPLAZID had another strong quarter driven by underlying volume growth, reflecting continued momentum in the business. In the fo...
-
Chime Reports Fourth Quarter and Full Year 2025 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Chime® (Nasdaq: CHYM), America’s #1 Choice for Banking1, today reported financial results for the quarter ended December 31, 2025. “We delivered strong results in 2025, with 31% year-over-year revenue growth, expanding margins, and growing momentum as the primary account of choice for mainstream America,” said Chris Britt, CEO and Co-founder of Chime. “Today, more Americans are choosing Chime as their primary account than any other financial institution. In 2026,...
-
Arlo Technologies to Present at Upcoming Investor Conferences
SAN JOSE, Calif.--(BUSINESS WIRE)--Arlo Technologies, Inc. (NYSE: ARLO), a leading provider of smart home security services, today announced that Arlo management will present at upcoming investor events. Event: Raymond James 47th Annual Institutional Investors Conference Speaker: Matthew McRae, CEO Date: Tuesday, March 3, 2026 Time: 1:05 p.m. ET Place: Orlando, FL Event: 38th Annual Roth Conference Speaker: Matthew McRae, CEO Date: Monday, March 23, 2026 Time: 9:30 a.m. PT P...